Literature DB >> 7049331

Cancer, chemotherapy and anaesthesia.

F Chung.   

Abstract

The main principle in anaesthetic management of cancer patients is caution in dosage because of the possibility of decreased cardiac and respiratory reserve, and possible obscured hepatic and renal impairment. The anaesthetic problems which should be anticipated in cancer patients who are on therapy are discussed and summarised in Table III. An understanding of these problems ensures greater safety during operation and quicker recovery in the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049331     DOI: 10.1007/bf03007527

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  50 in total

1.  Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems.

Authors:  M Nesbit; W Krivit; R Heyn; H Sharp
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

Review 2.  Neurotoxicity of commonly used antineoplastic agents (first of two parts).

Authors:  H D Weiss; M D Walker; P H Wiernik
Journal:  N Engl J Med       Date:  1974-07-11       Impact factor: 91.245

3.  Hypoglycemia associated with neoplasia.

Authors:  L J Marks; J Steinke; S Podolsky; R H Egdahl
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

4.  Metabolic and toxic effects of mithramycin during tumor therapy.

Authors:  B J Kennedy
Journal:  Am J Med       Date:  1970-10       Impact factor: 4.965

5.  Immunosuppressive therapy and anaesthesia.

Authors:  K B Vetten
Journal:  S Afr Med J       Date:  1973-05-12

6.  Renal toxicity of methotrexate.

Authors:  P T Condit; R E Chanes; W Joel
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

7.  Potentiation of the toxicity of adriamycin by propranolol.

Authors:  J Y Choe; A B Combs; K Folkers
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-09

8.  Manic reaction associated with procarbazine hydrochloride therapy of Hodgkin's disease.

Authors:  A M Mann; J L Hutchison
Journal:  Can Med Assoc J       Date:  1967-11-25       Impact factor: 8.262

9.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

10.  Hypercalcemia and hypocalcemia.

Authors:  F R Singer; J E Bethune; S G Massry
Journal:  Clin Nephrol       Date:  1977-04       Impact factor: 0.975

View more
  3 in total

Review 1.  Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.

Authors:  D S Klein; P R Wilds
Journal:  Can Anaesth Soc J       Date:  1983-07

2.  Anaesthesia for minor procedures in children with malignant disease.

Authors:  W R Hain; J H Tomlinson; P R Barbor
Journal:  J R Soc Med       Date:  1985-09       Impact factor: 5.344

3.  Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane.

Authors:  S Rosenow; K L Kooistra; G Powis; R A Van Dyke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.